- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
GlaxoSmithKline PLC
+ Add to WatchlistGS7:GR
20.490 EUR 0.120 0.59%As of 11:13:15 ET on 05/24/2013.
Snapshot for GlaxoSmithKline PLC (GS7)
| Open: | 20.355 | Day's Range: | 20.125 - 20.490 | Volume: | 32,529 |
|---|---|---|---|---|---|
| Previous Close: | 20.490 | 52wk Range: | 16.290 - 20.770 | 1-Yr Rtn: | +23.95% |
Key Statistics for GS7
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.9941 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (12/2013) | 1.1680 |
| Est. PEG Ratio | 2.1810 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 24,998 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 4.91% |
| Cash Dividend (GBp) | 18.0000 |
| Last Dividend | 05/08/2013 |
| 5 Year Dividend Growth | 3.91% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GS7
Company Profile & Key Executives for GS7
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
| Andrew WittyChief Executive Officer | Simon P DingemansChief Financial Officer |
| David RedfernChief Strategy Officer | Moncef SlaouiChairman:R&D & Vaccines |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GS7 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page